Source: Business Wire

Nuvig received $161M in Series B Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Julie Anne Smith

CEO Approval Rating

90/100

Nuvig is a California-based biopharmaceutical firm that researches and develops novel therapies for the treatment for chronic autoimmune diseases.